Risks for All-Cause Mortality: Stratified by Age, Estimated Glomerular Filtration Rate and Albuminuria

Nephron

Volumn 136, Issue 4, 2017, Pages 292-297

  Warnock, David G ^a   Delanaye, Pierre ^c   Glassock, Richard J ^b  

^a University of Alabama at Birmingham   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c UNIVERSITY OF LIÈGE   (Belgium)

Author keywords

Absolute risk; Incidence rate ratios; Relative risk; Serum creatinine

Indexed keywords

ADULT; AGE; AGED; ALBUMINURIA; CARDIOVASCULAR DISEASE; ESTIMATED GLOMERULAR FILTRATION RATE; FEMALE; GENDER; HUMAN; INCIDENCE; MAJOR CLINICAL STUDY; MALE; MORTALITY; MORTALITY RISK; PRIORITY JOURNAL; RACE; REVIEW; RISK FACTOR; SEX DIFFERENCE; SYSTOLIC BLOOD PRESSURE; GLOMERULUS FILTRATION RATE; MIDDLE AGED; PATHOPHYSIOLOGY; PHYSIOLOGY; RISK ASSESSMENT; TRENDS;

AGE FACTORS; AGED; ALBUMINURIA; FEMALE; GLOMERULAR FILTRATION RATE; HUMANS; INCIDENCE; MALE; MIDDLE AGED; MORTALITY; RISK ASSESSMENT;

EID: 85011705811     PISSN: 16608151     EISSN: 22353186     Source Type: Journal    
DOI: 10.1159/000455197     Document Type: Review

References (12)

1. Kidney Disease: Improving Global Outcomes (KDIGO) CKD Work Group: KDIGO 2012 clinical practice guideline for the evaluation and management of chronic kidney disease. Kidney Int Suppl 2013; 3: 1-150.
2. Hallan SI, Matsushita K, Sang Y, Mahmoodi BK, Black C, Ishani A, Kleefstra N, Naimark D, Roderick P, Tonelli M, Wetzels JF, Astor BC, Gansevoort RT, Levin A, Wen CP, Coresh J; Chronic Kidney Disease Prognosis Consortium: Age and association of kidney measures with mortality and end-stage renal disease. JAMA 2012; 308: 2349-2360.
3. Glassock R, Delanaye P, El Nahas M: An agecalibrated classification of chronic kidney disease. JAMA 2015; 314: 559-560.
4. Delanaye P, Glassock RJ, Pottel H, Rule AD: An age-calibrated definition of chronic kidney disease: Rationale and benefits. Clin Biochem Rev 2016; 37: 17-26.
5. Denic A, Glassock RJ, Rule AD: Structural and functional changes with the aging kidney. Adv Chronic Kidney Dis 2016; 23: 19-28.
6. Howard VJ, Cushman M, Pulley L, Gomez CR, Go RC, Prineas RJ, Graham A, Moy CS, Howard G: The reasons for geographic and racial differences in stroke study: Objectives and design. Neuroepidemiology 2005; 25: 135-143.
7. Howard VJ, Kleindorfer DO, Judd SE, Mc-Clure LA, Safford MM, Rhodes JD, Cushman M, Moy CS, Soliman EZ, Kissela BM, Howard G: Disparities in stroke incidence contributing to disparities in stroke mortality. Ann Neurol 2011; 69: 619-627.
8. Warnock DG: Estimated glomerular filtration rate: Fit for what purpose-Nephron 2016; 134: 43-49.
9. Inker LA, Schmid CH, Tighiouart H, Eckfeldt JH, Feldman HI, Greene T, Kusek JW, Manzi J, Van Lente F, Zhang YL, Coresh J, Levey AS; CKD-EPI Investigators: Estimating glomerular filtration rate from serum creatinine and cystatin C. N Engl J Med 2012; 367: 20-29.
10. Levey AS, de Jong PE, Coresh J, El Nahas M, Astor BC, Matsushita K, Gansevoort RT, Kasiske BL, Eckardt KU: The definition, classification, and prognosis of chronic kidney disease: A KDIGO controversies conference report. Kidney Int 2011; 80: 17-28.
11. Malmgren L, McGuigan FE, Berglundh S, Westman K, Christensson A, Akesson K: Declining estimated glomerular filtration rate and its association with mortality and comorbidity over 10 years in elderly women. Nephron 2015; 130: 245-255.
12. Levey AS, Inker LA, Coresh J: Chronic kidney disease in older people. JAMA 2015; 314: 557-558.